Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Journal of Virology|August 6, 2010
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridaeH Chen, Z Q Xiang, Y Li, et al.Nature Medicine|March 21, 2007
CD8(+) T-cell responses to adeno-associated virus capsid in humansFederico Mingozzi, Marcela V Maus, Daniel J Hui, et al.Antimicrobial Agents and Chemotherapy|September 20, 2021
The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 VariantsIan Tietjen, Joel Cassel, Emery T Register, et al.Cell Reports. Medicine|June 7, 2021
Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathwaysRamin Sedaghat Herati, Luisa Victoria Silva, Laura A Vella, et al.Journal of Medicinal Chemistry|September 11, 2024
Dually Labeled Neurotensin NTS1R Ligands for Probing Radiochemical and Fluorescence-Based Binding AssaysFabian J Ertl, Sergei Kopanchuk, Nicola C Dijon, et al.Annals of Surgery|October 30, 2018
Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical TrialGregory A Dumanian, Benjamin K Potter, Lauren M Mioton, et al.The Lancet. Infectious Diseases|May 1, 2026
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trialAdam J Ritchie, Omary Hassan, Nsiande Urasa, et al.Ebiomedicine|April 25, 2018
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus VectorsSteven Tuyishime, Larissa H Haut, Raj K Kurupati, et al.Frontiers in Veterinary Science|April 4, 2022
A One Medicine Mission for an Effective Rabies TherapyDarryn L Knobel, Alan C Jackson, John Bingham, et al.The Lancet. Microbe|July 30, 2022
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trialDaniel Jenkin, Adam J Ritchie, Jeremy Aboagye, et al.Pageof 16